MA
Molecular Partners AG
MOLN
SWISS EXCHANGEHealth Care
Income Statement
Total Revenue$5.64M
Gross Profit$5.64M
Operating Income$-69.37M
EBITDA$-58.67M
EBIT$-61.36M
Pre-tax Income$-76.64M
Net Income$-61.41M
Balance Sheet
Net Cash$823.59M
Cash Equivalent$74.74M
Total Debt$3.29M
Net Debt$-820.3M
Book Value$196.25M
Net Cash Per Share22.02
Book Value Per Share5.94
Key Ratios
Return on Equity (ROE)-38.16%
Return on Assets (ROA)-34.09%
Return on Invested Capital (ROI)-37.51%
Net Profit Margin-1087.38%
Current Ratio14.31
Quick Ratio14.10
Long-Term Debt / Equity1.55